​

Funding Round

Series A - Platelet BioGenesis

Series A - Platelet BioGenesis

Investment Firm

Overview

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Announced Date

Sep 09, 2019

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Qiming Venture Partners

Qiming Venture Partners

Qiming Venture Partners is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

1

Investor Name
Participant InvestorQiming Venture Partners

Round Details and Background

Platelet BioGenesis raised $26000000 on 2019-09-09 in Series A

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Company Funding History

14

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 14, 2017
Grant - Platelet BioGenesis
1-600.0K
Nov 04, 2021
Series B - Platelet BioGenesis
5-75.5M
Jun 08, 2017
Series A - Platelet BioGenesis
5-10.0M
Jul 28, 2016
Debt Financing - Platelet BioGenesis
-1.1M

Recent Activity

There is no recent news or activity for this profile.